.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Farmers Insurance
Mallinckrodt
Dow
Johnson and Johnson
Daiichi Sankyo
Cipla
Novartis
Medtronic

Generated: January 20, 2018

DrugPatentWatch Database Preview

Hepatitis C Virus NS5A Inhibitor Drug-Class List

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp DohmeZEPATIERelbasvir; grazoprevirTABLET;ORAL208261-001Jan 28, 2016RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Merck Sharp DohmeZEPATIERelbasvir; grazoprevirTABLET;ORAL208261-001Jan 28, 2016RXYesYes➤ Subscribe➤ Subscribe➤ Subscribe
Merck Sharp DohmeZEPATIERelbasvir; grazoprevirTABLET;ORAL208261-001Jan 28, 2016RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ Subscribe➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
Gilead Sciences IncVOSEVIsofosbuvir; velpatasvir; voxilaprevirTABLET;ORAL209195-001Jul 18, 2017RXYesYes➤ Subscribe➤ SubscribeYY➤ Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Accenture
Healthtrust
Boehringer Ingelheim
AstraZeneca
US Army
Argus Health
Chubb
Cantor Fitzgerald
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot